Ryan Specialty launches $160M restructuring, boosts buyback to $600M as organic growth slows

Filed October 30, 2026 · Period ending September 30, 2026 · Compared to 10-Q Oct 31, 2025 · ~1 min read

Key Changes

• high

  Empower Program restructuring expects $160 million in cumulative charges through 2028, funded by operating cash flow, targeting $80 million in annual savings by 2029.

  MD&A: Restructuring verify on EDGAR →
• high

  Share repurchase authorization increased by $300 million to $600 million; $450.3 million repurchased in the first nine months of 2026, with $150.0 million remaining.

  MD&A: Capital Allocation verify on EDGAR →
• high

  Organic revenue growth slowed to 4.0% in Q3 2026 from 15.0% a year earlier; nine-month growth fell to 7.3% from 11.4%.

  MD&A: Organic Growth verify on EDGAR →